Malignant Edema
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals (NCT01794182) | Remedy Pharmaceuticals, Inc. | 2013-06-13 |
Track Malignant Edema automatically
Every clearance here is in the API, with alerts when new ones post.